Outcomes in older patients with NSCLC receiving immunotherapy: A single center experience

J Geriatr Oncol. 2021 Sep;12(7):1104-1106. doi: 10.1016/j.jgo.2021.02.013. Epub 2021 Feb 19.
No abstract available

Keywords: Charlson comorbidity index; Geriatric oncology; Immune checkpoint inhibitor therapy; Immunosenescence; Lung cancer; NSCLC.

Publication types

  • Letter

MeSH terms

  • Aged
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Humans
  • Immunotherapy
  • Lung Neoplasms* / drug therapy